Royalty Pharma GC Says Law Limits Overcharge Payback
Royalty Pharma's general counsel testified Monday in the licensing company's €23 million ($27.6 million) unpaid royalties suit against Boehringer Ingelheim that the drugmaker waited too long to counterclaim for some overcharged...To view the full article, register now.
Already a subscriber? Click here to view full article